Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targeting Fibroblast Activating Protein (FAP) and is used in the study of colorectal cancer and non-small cell lung cancer.
CAS Number:
[216669-97-5]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted